Ozempic Maker Novo Nordisk Says Hackers Breached IT Systems

The pharmaceutical giant says the attackers gained access to personal data stored on the compromised systems. The post Ozempic Maker Novo Nordisk Says Hackers Breached IT Systems appeared first on SecurityWeek .

SecurityWeek reports that Novo Nordisk, maker of Ozempic, disclosed an IT security incident in which attackers gained unauthorized access to some internal systems and copied non-public personal data, including pseudonymized clinical trial information and identifiable data on certain healthcare professionals.[2][3] The company states that core operations remain unaffected but confirms that personal data was exfiltrated and that impacted parties are being notified.[2][3] From a CyberSE.AI perspective, this constitutes a significant data leakage event in a highly regulated healthcare context, highlighting the need for robust data segmentation, least-privilege access, strong monitoring of internal systems, and incident response preparedness before deploying or integrating AI systems that may touch the same data reservoirs. An AI Security Readiness Assessment would help map where sensitive clinical and patient-related data intersect with AI workflows, identify high-risk data flows and access paths, and define technical and governance controls to prevent similar exfiltration when AI tools or agents are introduced.